Latest St. Jude Medical (STJ) Headlines Kinaxis
Post# of 42
Posted On: 03/14/2014 8:54:33 AM
Latest St. Jude Medical (STJ) Headlines
Kinaxis Names Ronald A. Matricaria, Life Sciences Advisor, to its Board of Directors
PR Newswire - Tue Mar 11, 7:31AM CDT
Kinaxis®, provider of RapidResponse®, a cloud-based SCM and S&OP service, today announced the appointment of Mr. Ronald A. Matricaria to its board of directors. The addition of Matricaria adds deeper industry expertise in life sciences, a market that has seen continued growth for Kinaxis.
SmarTrend Watching for Potential Rebound in Shares of St Jude Medical After 1.32% Loss
Comtex SmarTrend(R) - Fri Mar 07, 4:19PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $66.75 to a high of $68.55. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $67.33 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
St Jude Medical Falls 1.32% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Mar 07, 4:19PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $66.75 to a high of $68.55. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $67.33 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Appointments, Earnings Results, Drug Applications, Conferences, and Approvals - Analyst Noteson Boston Scientific, Covidien, St. Jude Medical, Synageva BioPharma, and Ligand Pharmaceuticals
PR Newswire - Wed Mar 05, 3:00PM CST
Editor Note: For more information about this release, please scroll to bottom.
St. Jude's Growth Is Looking Sickly
at The Street - Tue Mar 04, 5:30AM CST
With the recent drop in St. Jude's margin, leading to a 5% decline in operating income, I just don't see how the stock makes sense right here.
Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow
M2 - Tue Mar 04, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/szcgxs/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Global Analysis and Market Forecasts" report to their offering. Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow The global electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems, is set to experience rapid growth in value over the coming years, climbing from approximately $1.56 billion in 2013 to $2.93 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.5%, says research and consulting firm The authors. The company's new report* forecasts that standard diagnostic catheters will achieve the largest revenue in the EP market by 2020, with a share of $2,493 million, followed by advanced diagnostic catheters and standard ablation catheters, with shares of $1,223 million and $575 million, respectively. According to the authors, this rapid EP industry growth is due to an increasing incidence of arrhythmia, along with rising market penetration of diagnostic and ablation catheters in the Asia-Pacific and South American regions. Rob Littlefield, MSc, Senior Analyst covering Medical Devices, says: Medical centers that support ablation are increasingly desirable as the global occurrence of cardiac dyssynchrony continues to rise. While atrial fibrillation and ventricular fibrillation are the most common indications for treatment, heart failure, diabetes and obesity can all contribute to ongoing rhythm management concerns. The authors states that the current EP market is extremely competitive and dominated by several key players, which must continue to innovate in the face of mounting price pressure and strict regulation, as new entrants battle to gain market share. Up-and-coming technologies in development, including alternative forms of energy such as cryo-, ultrasound- and laser-ablation, as well as advanced mapping and navigation technologies, promise to increase product sales and new account openings. Meanwhile, industry standards continue to develop in relation to ablation strategies for treatment, therefore improving patient outcomes, Littlefield concludes. This report provides a comprehensive analysis of the global electrophysiology market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, the UK, France, China, India, Japan and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Segment Analysis Market Outlooks by Market Segment Market Outlooks by Geography Strategic Competitive Assessment Current and Future Players Pipeline Product Assessment Strategic Deals Analysis Appendix List of Tables List of Figures Companies Mentioned Biosense Webster Biotronik Boston Scientific CardioFocus CardioInsight Hansen Medical Imricor Japan Lifeline Magnetecs Corporation Medtronic MicroPort Scientific Company St. Jude Medical Stereotaxis Stryker Sustainability Solutions Topera Medical For more information visit http://www.researchandmarkets.com/research/szcgxs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
St. Jude Medical to Present at the Barclays Global Healthcare Conference
Business Wire - Fri Feb 28, 2:04PM CST
St. Jude Medical, Inc. (NYSE:STJ) will present at the Barclays Global Healthcare Conference on Wednesday, March 12, in Miami. John Heinmiller, executive vice president, will address the conference at 10:15 a.m. EDT. The presentation will also be webcast live at www.sjm.com.
Global Optical Imaging Market Estimated to be Approximately Around $1.9 Billion by End of 2018, Growing at a CAGR of 11.37%
M2 - Thu Feb 27, 10:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/v44f8q/optical_imaging) has announced the addition of the "Optical Imaging Market (2013-2018) - Technology and Market Analysis Of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) And Photo- Acoustic Tomography (PAT) In Clinical Diagnostics & Research" report to their offering. The research service on "Advances in Optical Imaging (Medical Diagnostics & Clinical Research) - Technology Trends and Market Landscape Analysis" is an attempt to showcase the technology and market impact of existing and emerging optical imaging technologies having a huge growth potential in clinical medicine for the coming five years. This technology based research report categorizes optical imaging technologies based on applications, based on geography and on the basis of technicalities of various optical imaging modalities. Global optical imaging market can be estimated to be approximately around $1.9 billion by end of 2018, growing at a CAGR of 11.37%. Among the modalities, OCT occupies a major share contributing over 70% of the total optical imaging market. America is the major market for optical imaging equipments followed by Europe, and they have been driving the market significantly owing to the growth of aging population across the developed economies. Other than the mature markets, emerging economies such as Asia-pacific and Middle-East are the future drivers of optical imaging market. This report is further divided into segments and sub-segments providing exhaustive market analysis with respect to each technology from the years 2010 and 2011, as well as forecast up to 2018. Each technology is comprehensively analyzed at a granular level by geography (North America, EU, Asia and rest of the world) to provide in-depth information on the global scenario. Investment opportunity evaluation and emerging initial public offerings (IPOs) can be assessed within the optical imaging sector. Strategic recommendations for technology developers are elaborately discussed in this research service. Challenges: - Inadequate clinical data validation for optical methods restricts adoption. - Lack of reimbursement facilities. Companies Mentioned: - Ase Optics - Bioptigen, Inc. - Topcon Medical Systems, Inc. - Carl Zeiss Meditec - Chemimage Corporation - Cytoviva, Inc. - Headwall Photonics, Inc. - Heidelberg Engineering - Michelson Diagnostics Ltd ( Vivosight) - Raytheon Elcan Optical Technologies - Somanetics Corporation - St. Jude Medical - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/v4...al_imaging About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Does This Johnson & Johnson Product Have Blockbuster Potential?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Feb 26, 8:41AM CST
It's not often that a single clinical trial wipes out an entire therapeutic opportunity, but that is what most sell-side analysts seem to believe about 's U.S. pivotal trial...
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
St. Jude Medical Announces Increase in Quarterly Dividend
Business Wire - Mon Feb 24, 7:15AM CST
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its board of directors declared an 8 percent increase in the company's quarterly dividend to $0.27 per common share. The dividend is payable April 30, 2014, to shareholders of record on March 31, 2014. At the new rate, the annual dividend would be $1.08 per share, compared to the previous annual dividend of $1.00 per share.
Jim Cramer's 'Mad Money' CEO Chats: St. Jude Medical and Wyndham Worldwide
at The Street - Sat Feb 22, 5:00AM CST
Jim Cramer talks to St. Jude's CEO about its revolutionary pacemaker and the head of Wyndham about why its stock lags its earnings.
Can Boston Scientific Outperform the Index in 2014?
Peter Stephens, The Motley Fool - Motley Fool - Fri Feb 21, 5:07PM CST
The last five years have not been particularly happy ones for Boston Scientific , or for its shareholders. Indeed, the medical devices manufacturer has delivered a profit (in terms of adjusted earnings per share) in only three of the last five...
St Jude Medical Set to Possibly Pullback After Yesterday's Rally of 1.42%
Comtex SmarTrend(R) - Thu Feb 20, 4:34PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $66.46 to a high of $68.03. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $67.47 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
St Jude Medical Rises 1.42% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Feb 20, 4:34PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $66.46 to a high of $68.03. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $67.47 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Multiple Setbacks May Spell Opportunity at Medtronic, Inc.
Stephen D., Simpson,, The Motley Fool - Motley Fool - Thu Feb 20, 1:30PM CST
In a pretty richly valued med-tech space, it takes some setbacks to uncover value and opportunity. Medtronic has certainly seen setbacks, as the company has abandoned renal denervation, has lost some momentum in CRM, and may not be as competitive...
Clinical Trial at Sequoia Hospital Brings First Leadless Pacemaker to West Coast
PR Newswire - Wed Feb 19, 1:06PM CST
Dignity Health Sequoia Hospital's Heart and Vascular Institute and the physicians at Silicon Valley Cardiology have been selected by St. Jude Medical to participate in a clinical trial that will bring the first leadless pacemaker to the West Coast.
Medtronic Earnings Fall, But In Line With Street
at Investor's Business Daily - Tue Feb 18, 9:09AM CST
Medical device giant Medtronic (MDT) issued fiscal Q3 results and full-year guidance in line with Wall Street's expectations Tuesday, but still faced some significant head winds in its business. Medtronic shares were down 2.5% in early trading in the...
The Lessons to Be Learned From Keeping Score
Jason Moser, The Motley Fool - Motley Fool - Mon Feb 17, 5:30PM CST
As earnings season wraps up, I always like combing through my ideas to see which ones are working out and which ones still have some work to do. While I tend to invest with a three- to five-year timeline in mind, things can change quickly in the...
St Jude Medical Rises 2.01% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Feb 12, 4:59PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $64.11 to a high of $65.46. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $64.66 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Kinaxis Names Ronald A. Matricaria, Life Sciences Advisor, to its Board of Directors
PR Newswire - Tue Mar 11, 7:31AM CDT
Kinaxis®, provider of RapidResponse®, a cloud-based SCM and S&OP service, today announced the appointment of Mr. Ronald A. Matricaria to its board of directors. The addition of Matricaria adds deeper industry expertise in life sciences, a market that has seen continued growth for Kinaxis.
SmarTrend Watching for Potential Rebound in Shares of St Jude Medical After 1.32% Loss
Comtex SmarTrend(R) - Fri Mar 07, 4:19PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $66.75 to a high of $68.55. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $67.33 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
St Jude Medical Falls 1.32% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Mar 07, 4:19PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $66.75 to a high of $68.55. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $67.33 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Appointments, Earnings Results, Drug Applications, Conferences, and Approvals - Analyst Noteson Boston Scientific, Covidien, St. Jude Medical, Synageva BioPharma, and Ligand Pharmaceuticals
PR Newswire - Wed Mar 05, 3:00PM CST
Editor Note: For more information about this release, please scroll to bottom.
St. Jude's Growth Is Looking Sickly
at The Street - Tue Mar 04, 5:30AM CST
With the recent drop in St. Jude's margin, leading to a 5% decline in operating income, I just don't see how the stock makes sense right here.
Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow
M2 - Tue Mar 04, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/szcgxs/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Global Analysis and Market Forecasts" report to their offering. Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow The global electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems, is set to experience rapid growth in value over the coming years, climbing from approximately $1.56 billion in 2013 to $2.93 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.5%, says research and consulting firm The authors. The company's new report* forecasts that standard diagnostic catheters will achieve the largest revenue in the EP market by 2020, with a share of $2,493 million, followed by advanced diagnostic catheters and standard ablation catheters, with shares of $1,223 million and $575 million, respectively. According to the authors, this rapid EP industry growth is due to an increasing incidence of arrhythmia, along with rising market penetration of diagnostic and ablation catheters in the Asia-Pacific and South American regions. Rob Littlefield, MSc, Senior Analyst covering Medical Devices, says: Medical centers that support ablation are increasingly desirable as the global occurrence of cardiac dyssynchrony continues to rise. While atrial fibrillation and ventricular fibrillation are the most common indications for treatment, heart failure, diabetes and obesity can all contribute to ongoing rhythm management concerns. The authors states that the current EP market is extremely competitive and dominated by several key players, which must continue to innovate in the face of mounting price pressure and strict regulation, as new entrants battle to gain market share. Up-and-coming technologies in development, including alternative forms of energy such as cryo-, ultrasound- and laser-ablation, as well as advanced mapping and navigation technologies, promise to increase product sales and new account openings. Meanwhile, industry standards continue to develop in relation to ablation strategies for treatment, therefore improving patient outcomes, Littlefield concludes. This report provides a comprehensive analysis of the global electrophysiology market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, the UK, France, China, India, Japan and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Segment Analysis Market Outlooks by Market Segment Market Outlooks by Geography Strategic Competitive Assessment Current and Future Players Pipeline Product Assessment Strategic Deals Analysis Appendix List of Tables List of Figures Companies Mentioned Biosense Webster Biotronik Boston Scientific CardioFocus CardioInsight Hansen Medical Imricor Japan Lifeline Magnetecs Corporation Medtronic MicroPort Scientific Company St. Jude Medical Stereotaxis Stryker Sustainability Solutions Topera Medical For more information visit http://www.researchandmarkets.com/research/szcgxs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
St. Jude Medical to Present at the Barclays Global Healthcare Conference
Business Wire - Fri Feb 28, 2:04PM CST
St. Jude Medical, Inc. (NYSE:STJ) will present at the Barclays Global Healthcare Conference on Wednesday, March 12, in Miami. John Heinmiller, executive vice president, will address the conference at 10:15 a.m. EDT. The presentation will also be webcast live at www.sjm.com.
Global Optical Imaging Market Estimated to be Approximately Around $1.9 Billion by End of 2018, Growing at a CAGR of 11.37%
M2 - Thu Feb 27, 10:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/v44f8q/optical_imaging) has announced the addition of the "Optical Imaging Market (2013-2018) - Technology and Market Analysis Of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) And Photo- Acoustic Tomography (PAT) In Clinical Diagnostics & Research" report to their offering. The research service on "Advances in Optical Imaging (Medical Diagnostics & Clinical Research) - Technology Trends and Market Landscape Analysis" is an attempt to showcase the technology and market impact of existing and emerging optical imaging technologies having a huge growth potential in clinical medicine for the coming five years. This technology based research report categorizes optical imaging technologies based on applications, based on geography and on the basis of technicalities of various optical imaging modalities. Global optical imaging market can be estimated to be approximately around $1.9 billion by end of 2018, growing at a CAGR of 11.37%. Among the modalities, OCT occupies a major share contributing over 70% of the total optical imaging market. America is the major market for optical imaging equipments followed by Europe, and they have been driving the market significantly owing to the growth of aging population across the developed economies. Other than the mature markets, emerging economies such as Asia-pacific and Middle-East are the future drivers of optical imaging market. This report is further divided into segments and sub-segments providing exhaustive market analysis with respect to each technology from the years 2010 and 2011, as well as forecast up to 2018. Each technology is comprehensively analyzed at a granular level by geography (North America, EU, Asia and rest of the world) to provide in-depth information on the global scenario. Investment opportunity evaluation and emerging initial public offerings (IPOs) can be assessed within the optical imaging sector. Strategic recommendations for technology developers are elaborately discussed in this research service. Challenges: - Inadequate clinical data validation for optical methods restricts adoption. - Lack of reimbursement facilities. Companies Mentioned: - Ase Optics - Bioptigen, Inc. - Topcon Medical Systems, Inc. - Carl Zeiss Meditec - Chemimage Corporation - Cytoviva, Inc. - Headwall Photonics, Inc. - Heidelberg Engineering - Michelson Diagnostics Ltd ( Vivosight) - Raytheon Elcan Optical Technologies - Somanetics Corporation - St. Jude Medical - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/v4...al_imaging About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Does This Johnson & Johnson Product Have Blockbuster Potential?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Feb 26, 8:41AM CST
It's not often that a single clinical trial wipes out an entire therapeutic opportunity, but that is what most sell-side analysts seem to believe about 's U.S. pivotal trial...
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
St. Jude Medical Announces Increase in Quarterly Dividend
Business Wire - Mon Feb 24, 7:15AM CST
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its board of directors declared an 8 percent increase in the company's quarterly dividend to $0.27 per common share. The dividend is payable April 30, 2014, to shareholders of record on March 31, 2014. At the new rate, the annual dividend would be $1.08 per share, compared to the previous annual dividend of $1.00 per share.
Jim Cramer's 'Mad Money' CEO Chats: St. Jude Medical and Wyndham Worldwide
at The Street - Sat Feb 22, 5:00AM CST
Jim Cramer talks to St. Jude's CEO about its revolutionary pacemaker and the head of Wyndham about why its stock lags its earnings.
Can Boston Scientific Outperform the Index in 2014?
Peter Stephens, The Motley Fool - Motley Fool - Fri Feb 21, 5:07PM CST
The last five years have not been particularly happy ones for Boston Scientific , or for its shareholders. Indeed, the medical devices manufacturer has delivered a profit (in terms of adjusted earnings per share) in only three of the last five...
St Jude Medical Set to Possibly Pullback After Yesterday's Rally of 1.42%
Comtex SmarTrend(R) - Thu Feb 20, 4:34PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $66.46 to a high of $68.03. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $67.47 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
St Jude Medical Rises 1.42% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Feb 20, 4:34PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $66.46 to a high of $68.03. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $67.47 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Multiple Setbacks May Spell Opportunity at Medtronic, Inc.
Stephen D., Simpson,, The Motley Fool - Motley Fool - Thu Feb 20, 1:30PM CST
In a pretty richly valued med-tech space, it takes some setbacks to uncover value and opportunity. Medtronic has certainly seen setbacks, as the company has abandoned renal denervation, has lost some momentum in CRM, and may not be as competitive...
Clinical Trial at Sequoia Hospital Brings First Leadless Pacemaker to West Coast
PR Newswire - Wed Feb 19, 1:06PM CST
Dignity Health Sequoia Hospital's Heart and Vascular Institute and the physicians at Silicon Valley Cardiology have been selected by St. Jude Medical to participate in a clinical trial that will bring the first leadless pacemaker to the West Coast.
Medtronic Earnings Fall, But In Line With Street
at Investor's Business Daily - Tue Feb 18, 9:09AM CST
Medical device giant Medtronic (MDT) issued fiscal Q3 results and full-year guidance in line with Wall Street's expectations Tuesday, but still faced some significant head winds in its business. Medtronic shares were down 2.5% in early trading in the...
The Lessons to Be Learned From Keeping Score
Jason Moser, The Motley Fool - Motley Fool - Mon Feb 17, 5:30PM CST
As earnings season wraps up, I always like combing through my ideas to see which ones are working out and which ones still have some work to do. While I tend to invest with a three- to five-year timeline in mind, things can change quickly in the...
St Jude Medical Rises 2.01% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Feb 12, 4:59PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $64.11 to a high of $65.46. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $64.66 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
(0)
(0)St. Jude Medical (STJ) Stock Research Links
Scroll down for more posts ▼